Review
Sep 2026
Glycan recognition by DC-SIGN, Galectins, and Siglecs: structural insights and ligand-based drug design strategies- a review.
A framework for precision glycoimmunotherapy in cancer, infection, fibrosis, and autoimmunity is outlined, positioning lectins as dynamic immune checkpoints whose structural plasticity makes them compelling and tractable drug targets.
M. Mehra, M. Goswami, D. Negi
· Journal of Receptor and Sign... · 0 citations